Archive – Multinational Companies

How Swiss cobalt traders are trying to prevent child labour

This content was published on May 4, 2020 Swiss cobalt traders Glencore and Trafigura deal very differently with miners in the Democratic Republic of Congo, many of whom are children.

Novartis CEO warns that data on Covid-19 drugs is missing

This content was published on Apr 28, 2020 Potential pharmaceutical solutions to combat Covid-19 must have strong clinical data to back their efficacy, according to Novartis boss Vasant Narasimhan.

Roche boss who says bitter pill of truth is only way to build trust

This content was published on Apr 25, 2020 Severin Schwan talks a lot about trust. Trust in people you live with, socialise with, work with. And trust is not won by being nice.

Swiss deal on cystic fibrosis drugs could change price negotiations

This content was published on Apr 21, 2020 A deal between Swiss health authorities and Vertex brings relief to cystic fibrosis sufferers but also shows the power of patient advocacy.

Is Venezuela’s gold a liability for Switzerland?

This content was published on Apr 20, 2020 Venezuela is illegally mining and trading in gold, and Switzerland could be one of its clients, according to Swiss media reports.

Cautious reopening of some border points

This content was published on Apr 19, 2020 Five border crossing points with France are to be partially reopened on Monday following the announcement of a crisis exit plan.

SWISS expects to run only 20% of flights this summer

This content was published on Apr 19, 2020 Swiss Airlines currently expects to be running only 20% of its flight schedule this summer due to the coronavirus crisis, one of its directors says.

Government’s loosening lockdown plan under scrutiny

This content was published on Apr 19, 2020 Swiss Economics Minister Guy Parmelin says state aid to compnies coming out of coronavirus lockdown should not become a “pillow for laziness”.

Swiss medical manufacturers get reprieve as EU postpones new rules

This content was published on Apr 18, 2020 Swiss manufacturers have one year’s respite after the European Union decided to postpone new rules on approval of medical equipment.

Covid-19 therapy could come by end of year, vaccine in 2021

This content was published on Apr 14, 2020 Swiss pharma and business insiders predict that an effective drug therapy against Covid-19 will be available by the end of this year, but a vaccine might take a year longer than that.

Page 98 of 119

First … 96 97 98 99 100 … Last

Archive – Multinational Companies

Popular Stories

Most Discussed

Archive – Multinational Companies

More

How Swiss cobalt traders are trying to prevent child labour

More

Novartis CEO warns that data on Covid-19 drugs is missing

More

Roche boss who says bitter pill of truth is only way to build trust

More

Swiss deal on cystic fibrosis drugs could change price negotiations

More

Is Venezuela’s gold a liability for Switzerland?

More

Cautious reopening of some border points

More

SWISS expects to run only 20% of flights this summer

More

Government’s loosening lockdown plan under scrutiny

More

Swiss medical manufacturers get reprieve as EU postpones new rules

More

Covid-19 therapy could come by end of year, vaccine in 2021

Popular Stories

Most Discussed